年龄对减重手术并发症和死亡率的影响
本研究利用MBSAQIP数据登记库回顾2015-2016年接受袖状胃切除术或Roux-en-Y胃旁路术的患者,按年龄分组分析年龄对术后结局的影响。多因素分析显示,年龄>45岁者主要并发症和死亡率风险独立增加,提示延迟手术可能有害。
要点
- 年龄>45岁与主要并发症和30天死亡率风险增加独立相关。
- 尽管高龄患者术前BMI更低,但并发症和死亡率仍高于年轻患者。
- 减重手术对各年龄组总体死亡率风险仍较低。
核心结论
- 减重手术(SG或RYGB)对所有年龄组仍是低死亡率风险手术,但年龄>45岁者主要并发症和死亡率高于18-45岁患者。
研究设计与样本
- 回顾性队列研究,使用MBSAQIP数据登记库2015-2016年接受SG或RYGB的患者,排除修正和急诊手术后共279,419例,按年龄分为18-44、45-54、55-64、>65岁四组。
主要发现
- 单因素分析显示,随着年龄增加,BMI降低但RYGB比例和合并症指数升高(p<0.0001 vs 18-45岁)。
- 年龄>45岁时,主要并发症和30天死亡率增加,且不依赖于手术类型(p<0.0001)。
- 多因素分析控制合并症指数后,年龄>45岁仍增加主要并发症和死亡风险。
临床怎么用
- 对于年龄>45岁的肥胖患者,应充分评估手术风险,避免不必要的延迟。
- 高龄患者术前BMI较低但合并症较多,需加强围术期管理。
局限性
- 研究为回顾性设计,可能存在选择偏倚和未测量混杂因素。
- 仅纳入2015-2016年数据,结论外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Bariatric surgery is the most effective modality to treat obesity and obesity-related comorbidities. This study sought to utilize the MBASQIP® Data Registry to analyze the impact of age at time of surgery on outcomes following sleeve gastrectomy (SG) or Roux-en-Y gastric bypass (RYGB) procedures. METHODS: The MBSAQIP® Data Registry for patients undergoing SG or RYGB procedures between 2015 and 2016 was reviewed. Patients were divided into 4 age groups [18-44; 45-54; 55-64; > 65 years]. Minimal exclusions for revisional and/or emergency surgery were selected and combination variables created to classify complications as major or minor. A comorbidity index was constructed to include diabetes, gastroesophageal reflux disease (GERD), obstructive sleep apnea (OSA), and prior cardiac surgery. Univariate and multivariate logistic regression analyses were performed to compare age stratifications to the young adult (18-45 years) cohort. RESULTS: Of 301,605 cases, 279,419 cases (71.2% SG) remained after applying exclusion criteria (79.2% female, mean BMI 45.5 ± 8.1 kg/m2, 8.9% insulin-dependent diabetics). Mean age was 44.7 ± 12.0 years (51.3% 18-44 years; 26.9% 45-54 years; 16.3% 55-64 years; 5.5% > 65 years). A univariate analysis demonstrated preoperative differences of lower BMI with increasing age concomitant with increasing frequency of RYGB and a higher comorbidity index (p < 0.0001 vs. 18-45 years). At age > 45 years, major complications and 30-day mortality increased independent of procedure type (p < 0.0001). A multivariate analysis controlling for comorbidity indices demonstrated increasing age (> 45 years) increased risk for major complications and mortality. CONCLUSION: Overall, bariatric surgery (SG or RYGB) remains a low mortality risk procedure for all age groups. However, all age group classifications > 45 years had higher incidence of major complications and mortality compared to patients 18-45 years (despite older individuals having lower preoperative BMI) indicating delaying surgery is detrimental.
引用
- Maloney SR, Dugan N, Prasad T, et al. Impact of age on morbidity and mortality following bariatric surgery. Surg Endosc. 2019. PMID: 31667614. doi:10.1007/s00464-019-07201-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。